Discovery

18 Protein Sciences & Reagents CROs

18 qualified vendorsFree for buyersNeutral vendor of record
Quick answer

Protein Sciences and Reagents covers making the proteins and antibodies a discovery program runs on: gene-to-protein expression, purification, and custom reagent supply. You need it early in discovery, before assays, screening, and structural work can start. On BioBridgeX, buyers source and compare qualified CROs under one contract, free for buyers.

Protein Sciences & Reagents CROs (18)

Biocytogen

Unclaimed · public records

CRO · In Vitro Pharmacology, Target ID & Validation, Biomarker Discovery & Development

In Vitro PharmacologyTarget ID & ValidationBiomarker Discovery & DevelopmentOncologyHematologyMonoclonal Antibody (mAb)Bispecific / Multispecific Antibody

Twist Bioscience

Unclaimed · public records

CRO · Target ID & Validation, Assay Development & Screening, Hit-to-Lead

Target ID & ValidationAssay Development & ScreeningHit-to-LeadOncologyImmunology & InflammationMonoclonal Antibody (mAb)Bispecific / Multispecific Antibody

Abzena

Unclaimed · public records

CRO & CDMO · Assay Development & Screening, Hit-to-Lead, Lead Optimization

Assay Development & ScreeningHit-to-LeadLead OptimizationOncologyImmunology & InflammationMonoclonal Antibody (mAb)Bispecific / Multispecific Antibody

Adimab

Unclaimed · public records

CRO · Assay Development & Screening, Hit-to-Lead, Lead Optimization

Assay Development & ScreeningHit-to-LeadLead OptimizationOncologyImmunology & InflammationMonoclonal Antibody (mAb)Bispecific / Multispecific Antibody

GenScript

Unclaimed · public records

CRO & CDMO · Assay Development & Screening, Protein Sciences & Reagents, Medicinal & Synthetic Chemistry

Assay Development & ScreeningProtein Sciences & ReagentsMedicinal & Synthetic ChemistryOncologyImmunology & InflammationMonoclonal Antibody (mAb)Protein / Enzyme (Recombinant)

Proteros Biostructures

Unclaimed · public records

CRO · Assay Development & Screening, Hit-to-Lead, Structural Biology

Assay Development & ScreeningHit-to-LeadStructural BiologyOncologyImmunology & InflammationSmall MoleculePROTAC / Targeted Protein Degrader

HitGen

Unclaimed · public records

CRO · Assay Development & Screening, Hit-to-Lead, Lead Optimization

Assay Development & ScreeningHit-to-LeadLead OptimizationOncologyImmunology & InflammationSmall MoleculePROTAC / Targeted Protein Degrader

X-Chem

Unclaimed · public records

CRO · Assay Development & Screening, Hit-to-Lead, Lead Optimization

Assay Development & ScreeningHit-to-LeadLead OptimizationOncologyImmunology & InflammationSmall MoleculePROTAC / Targeted Protein Degrader

Aurigene Pharmaceutical Services

Unclaimed · public records

CRO & CDMO · Target ID & Validation, Assay Development & Screening, Hit-to-Lead

Target ID & ValidationAssay Development & ScreeningHit-to-LeadOncologyImmunology & InflammationSmall MoleculeMonoclonal Antibody (mAb)

Selvita

Unclaimed · public records

CRO · Target ID & Validation, Assay Development & Screening, Hit-to-Lead

Target ID & ValidationAssay Development & ScreeningHit-to-LeadOncologyCNS / NeurologySmall MoleculePROTAC / Targeted Protein Degrader

Domainex

Unclaimed · public records

CRO · Target ID & Validation, Assay Development & Screening, Hit-to-Lead

Target ID & ValidationAssay Development & ScreeningHit-to-LeadOncologyImmunology & InflammationSmall MoleculePROTAC / Targeted Protein Degrader

Sygnature Discovery

Unclaimed · public records

CRO · Target ID & Validation, Assay Development & Screening, Hit-to-Lead

Target ID & ValidationAssay Development & ScreeningHit-to-LeadOncologyCNS / NeurologySmall MoleculePeptide

Aragen Life Sciences

Unclaimed · public records

CRO & CDMO · DMPK / ADME, GLP Toxicology, Safety Pharmacology

DMPK / ADMEGLP ToxicologySafety PharmacologyOncologyCNS / NeurologySmall MoleculeMonoclonal Antibody (mAb)

Evotec

Unclaimed · public records

CRO & CDMO · In Vitro / Early Toxicology, DMPK / ADME, Safety Pharmacology

In Vitro / Early ToxicologyDMPK / ADMESafety PharmacologyOncologyCNS / NeurologySmall MoleculeMonoclonal Antibody (mAb)

Reaction Biology

Unclaimed · public records

CRO · Assay Development & Screening, In Vitro Pharmacology, Target ID & Validation

Assay Development & ScreeningIn Vitro PharmacologyTarget ID & ValidationOncologyImmunology & InflammationSmall MoleculePROTAC / Targeted Protein Degrader

Eurofins Discovery

Unclaimed · public records

CRO · In Vitro / Early Toxicology, Safety Pharmacology, DMPK / ADME

In Vitro / Early ToxicologySafety PharmacologyDMPK / ADMEOncologyCNS / NeurologySmall MoleculeMonoclonal Antibody (mAb)

WuXi AppTec

Unclaimed · public records

CRO & CDMO · GLP Toxicology, Safety Pharmacology, Genetic Toxicology

GLP ToxicologySafety PharmacologyGenetic ToxicologyOncologyCNS / NeurologySmall MoleculeMonoclonal Antibody (mAb)

Charles River Laboratories

Unclaimed · public records

CRO & CDMO · GLP Toxicology, Safety Pharmacology, Genetic Toxicology

GLP ToxicologySafety PharmacologyGenetic ToxicologyOncologyCNS / NeurologySmall MoleculeMonoclonal Antibody (mAb)

What is Protein Sciences and Reagents and when do you need it?

Protein Sciences and Reagents is the supply line that feeds the rest of discovery. Before you can run a binding assay, screen a library, solve a structure, or characterize a candidate, you need the actual protein in a tube: your target expressed and purified, the right reference reagents, and often a custom antibody or two. A CRO in this category designs the construct, picks an expression system, makes the protein, purifies it to the quality your downstream work demands, and ships you material you can trust. It sounds like plumbing, and in a sense it is, but a badly behaved protein quietly poisons every experiment that touches it.

You reach for this work at the very front of a program, usually in parallel with assay development rather than after it. The typical triggers are concrete: you have a new target and need milligram quantities of active, correctly folded protein for an assay; you need a panel of mutants or a tagged construct for an SPR or crystallography campaign; you need a custom polyclonal or monoclonal antibody as a detection reagent; or you need a hard-to-express membrane protein or multi-domain complex that your own lab has tried and failed to make. Many small biotechs simply do not own the fermentation, chromatography, and antibody-generation capacity to do this at the scale and quality a real screening or structural effort needs, so they outsource it.

The work spans expression systems and protein classes. E. coli for straightforward soluble proteins, baculovirus or insect cells and mammalian (HEK or CHO) systems for proteins that need glycosylation or proper folding, and cell-free systems for tricky cases. On the protein side this covers enzymes, kinases, receptors, antibodies and antibody fragments, fusion proteins, and the membrane proteins that are notoriously stubborn to express. On the reagent side it covers custom antibody generation (polyclonal, monoclonal, and increasingly recombinant), antibody conjugation and labeling, and reference standards. Most of this is research-grade work conducted under good documentation rather than GLP or GMP, though material destined for a regulated assay carries tighter quality expectations.

What does a Protein Sciences and Reagents CRO actually do?

The core deliverable is purified protein, and the path to it is more involved than "express and purify." A capable vendor takes a sequence or a target idea and works backward through construct design (tags, truncations, codon optimization, signal sequences), chooses and optimizes an expression system, scales the culture, then runs a purification train (affinity, ion exchange, size exclusion) to hit your purity and endotoxin targets. Just as important is the characterization that proves the protein is real: SDS-PAGE and Western blot for identity and purity, mass spec for intact mass, SEC-MALS or analytical ultracentrifugation for aggregation state and oligomerization, and a functional or activity assay to confirm the protein actually works, not just that it exists. A protein that runs clean on a gel but is half-aggregated or enzymatically dead is a common and expensive surprise.

On the reagent side, the same group often generates the antibodies and tool reagents a program needs. That includes custom antibody production by immunization or display, hybridoma development, recombinant antibody expression, fragment generation (Fab, scFv, VHH), and downstream conjugation to fluorophores, biotin, or other labels for use as detection reagents. The strongest vendors also handle the awkward jobs others avoid: difficult membrane proteins, large complexes, isotope-labeled protein for NMR, and milligram-to-gram scale-ups when a screening campaign or animal study needs more material than a single prep yields.

How to choose a Protein Sciences and Reagents CRO?

The deciding factor is rarely price. It is whether this group can make your specific protein well, at the quality and quantity your downstream work needs, on a timeline that does not stall the program. A vendor that excels at soluble E. coli enzymes may struggle with a glycosylated receptor or a seven-transmembrane target, so match the shop to the protein in front of you before you compare quotes. Ask for relevant case studies in your protein class and expression system, and confirm the people who would run your project have actually made something like it.

  • Quality and documentation: confirm the grade you need (research-grade is the norm here, but ask about endotoxin limits, lot-to-lot consistency, certificates of analysis, and GLP or GMP posture if the material feeds a regulated assay or animal study).
  • Capacity and lead time: ask for a realistic timeline through construct design, expression, purification, and characterization, and what historically causes slippage. A difficult protein can take several attempts, so build that into the schedule rather than assuming a single clean run.
  • Modality and target fit: match the vendor to your protein class and expression system (E. coli, insect, mammalian, cell-free) and to your modality, whether that is a kinase, a membrane protein, an antibody panel, or a fusion construct for a structural campaign.
  • Region and regulatory track record: confirm where the work is run and whether their quality system fits your filing geography if the material will ever support regulated work; for purely exploratory reagents this matters less.
  • Data quality and characterization: insist on a defined characterization package (purity, identity, aggregation state, activity) so you receive proof the protein is folded and functional, not just a gel image.
  • IP and confidentiality: settle who owns constructs, cell lines, hybridomas, and sequences before work starts, confirm how material and data transfer to you, and check the CDA covers a target you may not want disclosed.

Frequently asked questions

What is the difference between protein expression and protein purification?
Expression is making the protein: you put your gene into a host system (E. coli, insect, or mammalian cells, or a cell-free system) and let the cells produce it. Purification is separating that protein from everything else in the cell soup, usually through affinity, ion exchange, and size-exclusion chromatography, until it is clean enough to use. A good CRO does both as one workflow, plus the characterization that proves the purified protein is folded, active, and the right molecular weight. The two steps are scoped together because a protein that expresses well but cannot be purified cleanly is not usable.
Which expression system should I use for my protein?
It depends on the protein. E. coli is fast and cheap and works well for soluble proteins that do not need mammalian-style folding or glycosylation. Baculovirus or insect cells handle many proteins that E. coli cannot fold. Mammalian systems (HEK or CHO) are the choice when you need human-like glycosylation, secreted proteins, antibodies, or large multi-domain targets, at higher cost and longer timelines. Cell-free systems help with toxic or very difficult proteins. A vendor with experience across systems will recommend one based on your protein class rather than defaulting to whatever they run most often, so ask them to justify the choice.
Do protein sciences and reagents need to be GLP or GMP?
Usually not. The great majority of discovery protein and reagent work is research-grade, made under good documentation and quality practice but not under GLP or GMP. GLP applies to the regulated safety studies later in development, and GMP applies to clinical and commercial manufacturing, neither of which is where your assay reagents and screening protein sit. That said, if a protein or antibody will feed a regulated assay, support an IND-enabling study, or be dosed in animals, the quality bar rises, so tell the vendor the intended use up front and confirm endotoxin limits, lot consistency, and documentation match it.
How long does custom protein production take?
For a well-behaved protein in a standard system, plan in weeks from construct to purified, characterized material. Difficult targets stretch that out: membrane proteins, large complexes, and proteins that need extensive construct screening or expression optimization can take a couple of months and several attempts before you have usable material. Custom antibody generation runs on its own clock, often a few months for immunization, screening, and characterization. The honest move is to ask the vendor for a staged timeline with a checkpoint after the first expression trial, so you find out early whether your protein is easy or stubborn.
Who owns the constructs, cell lines, and antibodies a CRO makes for me?
Settle this before any work starts. In a clean arrangement the buyer owns the constructs, stable cell lines, hybridomas, sequences, and the protein and antibodies produced under the funded project. Watch for vendors whose platform terms claim rights to cell lines or reagents derived from their technology, and confirm in writing how physical material, sequences, and characterization data transfer to you at the end. For antibody work in particular, clarify ownership of the hybridoma or the recombinant sequence, because that determines whether you can have the reagent re-made elsewhere later.
Is sourcing a protein sciences CRO on BioBridgeX free for buyers?
Yes. BioBridgeX is free for buyers. Vendors pay a flat 2% platform fee, the same rate on a single antibody project or a multi-protein expression package, so the quotes you see are not padded with buyer-side markups. Because BioBridgeX is a neutral vendor of record with no lab of its own, it has no reason to steer you toward a preferred shop. When a discovery program needs a protein vendor alongside a screening CRO and a structural lab, you still sign one contract, raise one purchase order, and receive one invoice across all of them.

Source Protein Sciences & Reagents with one contract

Compare transparent quotes from qualified Protein Sciences & Reagents CROs, then contract once. Free for buyers.

Compare quotes